Shanghai Hile Bio-Technology Co Ltd - Class A

SHSE:603718 (China)   Class A
Â¥ 6.44 (-4.73%) Jun 20
94.71
P/B:
3.46
Market Cap:
Â¥ 4.24B ($ 583.55M)
Enterprise V:
Â¥ 4.18B ($ 575.62M)
Volume:
11.71M
Avg Vol (2M):
6.49M
Trade In:
Volume:
11.71M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Shanghai Hile Bio-Technology Co Ltd ( ) from 2015 to Jun 20 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Shanghai Hile Bio-Technology stock (SHSE:603718) PE ratio as of Jun 20 2024 is 94.71. More Details

Shanghai Hile Bio-Technology Co Ltd (SHSE:603718) PE Ratio (TTM) Chart

To

Shanghai Hile Bio-Technology Co Ltd (SHSE:603718) PE Ratio (TTM) Historical Data

Total 1211
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Shanghai Hile Bio-Technology PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-20 94.7 2024-04-12 124.8
2024-06-19 99.4 2024-04-11 128.5
2024-06-18 101.5 2024-04-10 129.8
2024-06-17 98.8 2024-04-09 134.4
2024-06-14 102.2 2024-04-08 131.8
2024-06-13 106.3 2024-04-05 136.9
2024-06-12 113.2 2024-04-03 136.9
2024-06-11 102.9 2024-04-02 135.3
2024-06-07 101.5 2024-04-01 136.8
2024-06-06 97.5 2024-03-29 137.2
2024-06-05 104.1 2024-03-28 132.5
2024-06-04 104.1 2024-03-27 91.2
2024-06-03 106.2 2024-03-26 92.5
2024-05-31 109.8 2024-03-25 95.2
2024-05-30 107.9 2024-03-22 98.0
2024-05-29 109.0 2024-03-21 96.1
2024-05-28 108.2 2024-03-20 87.3
2024-05-27 110.2 2024-03-19 85.9
2024-05-24 111.8 2024-03-18 86.3
2024-05-23 111.9 2024-03-15 85.7
2024-05-22 116.0 2024-03-14 85.1
2024-05-21 116.6 2024-03-13 84.6
2024-05-20 119.1 2024-03-12 85.4
2024-05-17 118.7 2024-03-11 83.4
2024-05-16 117.1 2024-03-08 80.9
2024-05-15 118.4 2024-03-07 80.8
2024-05-14 122.7 2024-03-06 82.7
2024-05-13 122.2 2024-03-05 83.0
2024-05-10 126.6 2024-03-04 83.9
2024-05-09 131.5 2024-03-01 83.4
2024-05-08 128.5 2024-02-29 84.1
2024-05-07 125.3 2024-02-28 81.7
2024-05-06 124.6 2024-02-27 86.4
2024-04-30 121.0 2024-02-26 84.3
2024-04-29 123.5 2024-02-23 84.4
2024-04-26 119.6 2024-02-22 82.3
2024-04-25 120.4 2024-02-21 81.2
2024-04-24 118.8 2024-02-20 81.0
2024-04-23 117.7 2024-02-19 81.1
2024-04-22 114.6 2024-02-16 79.7
2024-04-19 112.8 2024-02-09 79.7
2024-04-18 114.8 2024-02-08 79.7
2024-04-17 116.9 2024-02-07 72.5
2024-04-16 108.7 2024-02-06 71.7
2024-04-15 118.5 2024-02-05 66.7

Shanghai Hile Bio-Technology Co Ltd (SHSE:603718) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Shanghai Hile Bio-Technology Co Ltd is a veterinary biological product manufacturer integrating research and development, production, sales, and service. The company has over 40 categories of poultry, livestock, and pets. The company provides services for the prevention of livestock diseases, improving the health of livestock and poultry, and improving the production efficiency of farmers, and is able to provide comprehensive solutions and an authoritative veterinary expert service system.